Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.

Orkin AM; Gill PJ; Ghersi D; Campbell L; Sugarman J; Emsley R; Steg PG; Weijer C; Simes J; Rombey T

doi:10.1001/jama.2021.9941

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.

Identifier:nobleid.org/w1/20260526/681DFAAB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/681DFAAB.svg?ark=w1%2F20260526%2F681DFAAB)](https://nobleid.org/work/w1/20260526/681DFAAB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.

Identifier:nobleid.org/w1/20260526/681DFAAB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/681DFAAB.svg?ark=w1%2F20260526%2F681DFAAB)](https://nobleid.org/work/w1/20260526/681DFAAB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work